Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-17

Clinical Trial Update: Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating pazopanib in combination with FOLFOX6 or CapeOx in colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Colorectal | Phase 1 | Status: COMPLETED